Figure 1. 2nd MSA patient on nasal foralumab

Figure 1. 2nd MSA patient on nasal foralumab

Significant reduction in basal ganglia and thalamic uptake following nasal foralumab

Format

PNG

Quelle:

Tiziana Life Sciences Ltd.

Downloads